Evaluation of anti-tumor effevts mediated by engineered T lymphocytes expressing a CD19 specific CAR for B cell lymphoma
Evaluation of anti-tumor effevts mediated by engineered T lymphocytes expressing a CD19 specific CAR for B cell lymphoma
复制标题
表达 CD19 特异性 CAR 的工程化 T 淋巴细胞介导的 B 细胞淋巴瘤抗肿瘤效果评估
DOI:
--
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Ozawa K.
中科院分区:
文献类型:
--
作者:
Tsukahara T;Ohmine K;Uchibori R;Ido H;Urabe M;Mizukami H;Kume A;Nakamura M;Riviere I;Sadelain M;Brentjens R;Ozawa K.